Concho Resources Inc. (CXO) Financials Nov 14, 2014, 4:29

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
Concho Resources Inc. (CXO) Financials Nov 14, 2014, 4:29 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Concho Resources Inc.


Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 544.45M 940.27M 1.74B 1.82B 2.32B
Cost of Goods Sold (COGS) incl. D&A 324.92M 418.38M 751.13M 962.9M 1.29B
COGS excluding D&A 118.78M 176.73M 319.79M 383.58M 515.23M
Depreciation & Amortization Expense 206.14M 241.64M 431.34M 579.32M 778.66M
Depreciation 204.59M - 429.79M - 777.19M
Amortization of Intangibles 1.56M - 1.55M - 1.46M
Gross Income 219.53M 521.89M 988.84M 856.92M 1.03B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 41.09M - 96.26M 133.8M 169.82M
Research & Development 0 - 0 0 -
Other SG&A 41.09M 65.15M 96.26M 133.8M 169.82M
Other Operating Expense 1.06M - 0 0 0
Unusual Expense 261.62M (98.94M) (61.07M) (103.91M) 267.4M
EBIT after Unusual Expense (261.62M) 98.94M 61.07M 103.91M (267.4M)
Non Operating Income/Expense 82M - (88.83M) 14.95M (13.08M)
Non-Operating Interest Income - - - 0 0
Equity in Affiliates (Pretax) 0 - 0 0 0
Interest Expense 28.29M 60.09M 118.36M 182.71M 218.58M
Gross Interest Expense 28.29M 60.09M 118.43M 182.71M 218.58M
Interest Capitalized - - 73,000 0 0
Pretax Income (30.53M) 285.93M 746.45M 659.27M 357.16M
Income Tax (20.73M) 115.28M 285.85M 251.04M 118.24M
Income Tax - Current Domestic 10.19M - 24.16M 9.22M 15.81M
Income Tax - Current Foreign 0 - 0 - -
Income Tax - Deferred Domestic (30.92M) - 261.69M 241.82M 102.43M
Income Tax - Deferred Foreign 0 - 0 - -
Income Tax Credits 0 - 0 - 0
Equity in Affiliates 0 - 0 0 0
Other After Tax Income (Expense) 0 - 0 0 (2.61M)
Consolidated Net Income (9.8M) 170.65M 460.6M 408.23M 236.31M
Minority Interest Expense 0 0 0 0 0
Net Income (9.8M) 170.65M 460.6M 408.23M 236.31M
Extraordinaries & Discontinued Operations 0 33.72M 87.53M 23.46M 11.95M
Extra Items & Gain/Loss Sale Of Assets 0 - 0 0 11.95M
Cumulative Effect - Accounting Chg - - 0 0 0
Discontinued Operations 0 33.72M 87.53M 23.46M 0
Net Income After Extraordinaries (9.8M) 204.37M 548.14M 431.69M 248.26M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (9.8M) 170.65M 460.6M 408.23M 236.31M
EPS (Basic) (0.12) 2.21 5.34 4.18 2.28
Basic Shares Outstanding 84.91M 92.54M 102.58M 103.19M 103.74M
EPS (Diluted) (0.12) 2.18 5.28 4.15 2.27
Diluted Shares Outstanding 84.91M 93.84M 103.65M 103.97M 103.91M
EBITDA 383.52M 696.91M 1.32B 1.3B 1.63B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Altea Targets US Market, Appoints Rodrick VP Amid Expansion

Updated Category News Views 58

Wading into the murky waters of U.S. healthcare insurance isn't for the faint of heart, but Altea's making its move. Backed by MISSION, they're banking on a niche strategy by tapping veteran Justin Rodrick as Vice President. Their tactic? Aim squarely at the under-served segment of small to mid-sized medical and healthcare facilities. The play's bold, and if Rodrick's got...

Continue Reading
Navigating Home Care: What Families Need to Know

Updated Category News Views 94

Peeking into the Home Care Playbook The process of starting home care isn't some mind-boggling puzzle. For families in Northeastern Pennsylvania, things kick off with a cordial chinwag with a care coordinator—no paperwork chains or Kafkaesque contracts right off the bat. Now, if you've got someone in need of care, this gives you time to shove all your questions onto the...

Continue Reading
Innovative Trial Targets Drug Resistance in Lung Cancer

Updated Category News Views 0

The Battle Against Drug Resistance Heats Up Folks, we're in a never-ending fight here against one of the toughest adversaries out there: lung cancer. And lemme tell ya, when drugs show resistance, it's like trying to punch a ghost. But there’s a fresh wind blowing, as Dr. Bobak Parang steps up to the plate with a $620K grant aimed squarely at tackling drug resistance in...

Continue Reading
Kimberly-Clark Extends Kenvue Notes Exchange Deadline

Updated Category News Views 72

Deadline Extended for Kenvue's Noteholders In the wild world of corporate finance, the only thing more unpredictable than the weather is a boardroom decision. Kimberly-Clark (NASDAQ: KMB) just threw one such curveball by extending the deadline on their exchange offers for Kenvue Notes to November 2, 2026. Seems like 5 p.m. New York time is the new witching hour for this...

Continue Reading
Epilepsy Market's Explosive Growth Forecasted to 2036

Updated Category News Views 113

It's a wild world out there for epilepsy treatments—like a relentless bull run with everyone eyeing the prize. The latest buzz points to a fat 2036 forecast for this sector, driven by a mix of standout technologies and breakthrough therapies. You'd be a fool to blink and miss it. Rising Numbers Stir the Market The numbers, oh boy, they're climbing. In 2025, about 7...

Continue Reading
Don Silvestri: NFL Vet's Service Legacy Continues

Updated Category News Views 64

More Than Just a Debt Guru It's not every day you see a former NFL player shifting gears so smoothly into the corporate world, and then to community service like a missile lock. But that's exactly what Don Silvestri, president of Debt.com, has done. Dragging a hefty reputation as a placekicker for teams like the New York Jets and the Buffalo Bills, he's now making...

Continue Reading
CORE Embraces Tech to Boost Organ Donation Efforts

Updated Category News Views 73

Innovation Meets Organ Donation Out of all the business moves you hear about, this one rings loud because it doesn’t just move the needle on a spreadsheet—it moves the needle on life or death. The Center for Organ Recovery & Education (CORE) is stepping into the future with a high-tech touch to enhance their lifesaving mission. Partnering with InVita Healthcare...

Continue Reading
MillerKnoll's 3D Push: Legacy Meets Innovation

Updated Category News Views 42

Bringing the Classics to the Digital Frontier Here's what's lighting a fire under the world of high-end furniture: MillerKnoll's got its eye on the prize by jazzing up Knoll.com with shiny new 3D product configurators. It's like taking a century's worth of design stuffiness and spinning it into the future, ready to dazzle a whole new set of eyeballs. Why This Move Matters...

Continue Reading
Dotwork's AI Leap: Acquires Arcario to Revolutionize Strategy

Updated Category News Views 84

Transformations in enterprise management are knocking at the door with Dotwork's latest move. Their strategic acquisition of Arcario Group aims to flip the lid on how companies tie strategies to their daily grind using AI. Let me level with you—this ain't about just spicing up some dashboards or workflows. We're talking about an enterprise-level overhaul in the very way...

Continue Reading
Boeing's Third Quarter 2026: Progress Amid Losses

Updated Category News Views 97

Boeing's Rocky Rollercoaster Ride This Quarter Man, if you want a case study on turbulence in the business world, look no further than Boeing's recent third-quarter performance. This juggernaut managed to clock in $24.2 billion in revenues, up 4% from last year, but it still can't seem to shake off its streak of red ink. We're talking a net loss of $116 million, or a GAAP...

Continue Reading

Top 5 Most Recently Viewed Articles

SMCP Reports Strong Sales Growth Backed by Strategic Plans

Updated Category News Views 229

Strong Sales Growth in Q3 for SMCP The latest sales report for SMCP has highlighted a solid growth trajectory in the third quarter. The performance is attributed to robust activities in the America and EMEA regions, showcasing the effectiveness of the company's strategic initiatives. Sales Overview and Highlights In the first nine months of 2025, SMCP achieved impressive...

Continue Reading
InflaRx Set to Showcase Innovations at Upcoming Investor Events

Updated Category News Views 187

InflaRx to Participate in Major Investor Conferences In a noteworthy announcement, InflaRx N.V. (Nasdaq: IFRX), a leading biopharmaceutical company specializing in anti-inflammatory therapeutics, is gearing up for participation in two significant investor conferences in September. This engagement comes as the company continues to push boundaries in treating inflammatory...

Continue Reading
Rapid7's Participation at Major Industry Conference

Updated Category News Views 141

Rapid7 to Attend Prominent Conference Rapid7, Inc. (NASDAQ:RPD), a frontrunner in threat detection and exposure management, has recently announced its participation in a significant event: the Raymond James TMT and Consumer Conference. This notable conference will take place in New York, providing a platform where industry leaders gather to discuss innovations and...

Continue Reading
Theriva Biologics Expands Opportunities with New Offering

Updated Category News Views 136

Theriva Biologics Expands Opportunities with New Offering Theriva Biologics (NYSE American: TOVX), a clinical-stage company focused on developing innovative cancer therapeutics, has recently completed a significant public offering aimed at raising $7.5 million. This initiative is not only a financial step for Theriva but also a strategic move to enhance its research...

Continue Reading
Costco Welcomes Gina Raimondo to its Board of Directors

Updated Category News Views 211

Costco's New Board Nominee Costco Wholesale Corporation (NASDAQ: COST) has announced the nomination of Gina Raimondo to its Board of Directors. Raimondo, who has an impressive track record, served as the 40th Secretary of Commerce and held the position of Governor of Rhode Island. Her political career began in 2010 when she was elected as the Treasurer of Rhode Island....

Continue Reading